U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06959251) titled 'Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia' on April 28.
Brief Summary: * Patients with primary ciliary dyskinesia (PCD) have trouble with clearing their bronchi from mucus, which in the long-term may produce severe damage to the lungs. Currently, there is no specific treatment for PCD beyond supportive measures such as airway hydration and postural drainage.
* Glycine is an amino acid with anti-inflammatory properties that proved to be beneficial in another disease with problematic airway clearance, cystic fibrosis.
* Magnesium participates in many crucial chemical reactions, including some that ...